Senior team

With expertise in research, fundraising, policy and more, our staff and key spokespeople are dedicated to making breakthroughs possible.

Hilary Evans

Chief Executive

Hilary Evans is Chief Executive of Alzheimer’s Research UK.

Read full biography

As Chief Executive Hilary has led the transformation of the charity to one of the leading medical research charities in the UK – seeing the charity more than triple its income in three years and therefore significantly enhanced the organisations ability to fund groundbreaking new projects.

Before joining Alzheimer’s Research UK Hilary led the campaigning work at Age UK, improving the lives of people in later life both in the UK and internationally.

Ian Wilson

Executive Director of Fundraising and Communications

Ian joined Alzheimer’s Research UK in September 2013 and is responsible for leading our fundraising, marketing and communications activities.

Read full biography

In order to overcome dementia it is critical that Alzheimer’s Research UK continues to build awareness and understanding of the key issues at hand, and to raise the funding needed to drive forward our research programme.

Alzheimer’s Research UK is reliant on the generosity of the general public to help meet our vision of a world free from the fear, harm and heartbreak of dementia.

Prior to this appointment, Ian was the Head of Campaigns at Cancer Research UK with the responsibility for delivering funding towards a number of multi-million pound projects within the organisation.

Philip Dunn

Executive Director of Finance and Operations

Philip joined Alzheimer’s Research UK in January 2017 and is responsible for the delivery of effective corporate support and governance.

Read full biography

He oversees the Corporate Services Directorate, which covers Finance, HR, Governance, Facilities and Information Service functions. It is vital that we deliver effective and efficient support functions as well as driving good governance and compliance across the Charity, to underpin core activities taking place in other Directorates.

Philip has a strong background in financial and commercial roles across a variety of Industry sectors. In the last 10 years Philip’s time has been spent working at Johnson Matthey, Sopra Steria and CarilllionAmey.

Dr Carol Routledge

Director of Research

Dr Carol Routledge is the Director of Research at Alzheimer’s Research UK where she currently drives the research agenda.

Read full biography

Carol moved to the charity in 2017 from the Dementia Discovery Fund, where she was a Venture Partner with a key focus on identifying and developing novel disease-modifying mechanisms for the treatment of all types of dementia, sourcing opportunities from academic research groups and small companies.

She has had a successful career with a number of UK and US based major pharmaceutical and biotechnology companies, with leadership roles in drug acquisition and translational medicine strategies, with a focus on neuroscience.

A combination of preclinical and clinical experience gives her the advantage of being able to apply a strong scientific rationale and innovative experimental approaches to clinical development.

Carol has a PhD in neuropharmacology from Queens Medical School in Nottingham.

Timothy Parry

Director of Communications, Brand and Partnerships

Tim has overseen the growth of Alzheimer’s Research UK’s communications, establishing its press office in 2008.

Read full biography

The charity is now the leading voice on dementia science in the UK media thanks to its award-winning team.

Tim’s role is responsible for Alzheimer’s Research UK’s media, health information and science communications functions, as well as its digital and social media work and branding.

Tim has 13 years’ experience in PR and corporate communications across the public, corporate and voluntary sectors.

Carolyne Coupel

Director of Marketing, Data and Insight

Carolyne joined Alzheimer’s Research UK in 2014.

Read full biography

Her team are responsible for generating 50% of the charities income through ambitious direct marketing programmes across cash, regular giving, legacy and in memoriam giving. She also manages the Supporter Care function, aiming to delight supporters at every touch point.

Carolyne has been Head of Individual Giving at both The Children’s Society and The National Autistic Society.

Prior to her time in the charity sector, Carolyne was Head of Marketing at Telewest Broadband.

Lucy Squance

Director of Supporter-led Fundraising

Since starting Alzheimer’s Research UK in 2016, Lucy has built a successful department enabling supporters to fundraise through leveraging their own talents and passions.

Read full biography

Her team includes; Sporting Events, Regional Corporate, Community Fundraising and the Central Fundraising Team.

With previous commercial marketing and PR roles, Lucy started her fundraising career at Cancer Research UK in 2004.

She then worked as an interim manager and freelance consultant in the sector specialising in troubleshooting fundraising processes, developing robust fundraising strategies and establishing high performing teams.

Dr David Reynolds

Chief Scientific Advisor

David Reynolds is our Chief Scientific Advisor, having previously held the post of Chief Scientific Officer at Alzheimer’s Research UK for three years.

Read full biography

David now works for the Dementia Discovery Fund, the world’s largest venture fund focused on discovering and developing novel therapies for dementia, including Alzheimer’s disease. His role is focussed on creating biotech companies that translate UK dementia science into drug discovery activities, including research that has been supported by ARUK.

Previously David has worked in the pharmaceutical industry for 18 years at Merck Sharp & Dohme, Lundbeck and latterly Pfizer, where he was the Cambridge Neuroscience & Pain research site head. He has held a variety of R&D leadership roles with responsibilities ranging from exploratory biology, through drug discovery, early clinical development and business development in multiple disease areas, but with a focus on neuroscience and pain.

He has served as a member of the Medical Research Council’s Neuroscience and Mental Health Board, various ad hoc advisory boards and also provides expert drug discovery advice to neuroscience biotechs. David holds a BA in Natural Sciences and a PhD in Neuropharmacology both from the University of Cambridge and is a visiting professor at the Institute of Neurology at University College London.